Armstrong Shaw Associates’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$213K Hold
1,900
0.22% 42
2023
Q2
$277K Hold
1,900
0.28% 38
2023
Q1
$245K Hold
1,900
0.24% 43
2022
Q4
$242K Buy
+1,900
New +$220K 0.24% 39
2022
Q2
Sell
-1,900
Closed -$243K 43
2022
Q1
$243K Sell
1,900
-57
-3% -$6.87K 0.2% 42
2021
Q4
$241K Hold
1,957
0.2% 42
2021
Q3
$278K Hold
1,957
0.24% 38
2021
Q2
$306K Hold
1,957
0.27% 37
2021
Q1
$304K Hold
1,957
0.28% 37
2020
Q4
$293K Hold
1,957
0.29% 36
2020
Q3
$259K Hold
1,957
0.31% 36
2020
Q2
$227K Buy
+1,957
New +$226K 0.28% 42
2020
Q1
Sell
-1,957
Closed -$284K 48
2019
Q4
$284K Hold
1,957
0.25% 44
2019
Q3
$261K Hold
1,957
0.24% 44
2019
Q2
$224K Hold
1,957
0.2% 43
2019
Q1
$243K Buy
+1,957
New +$222K 0.23% 39
2018
Q4
Sell
-1,957
Closed -$250K 42
2018
Q3
$250K Hold
1,957
0.21% 40
2018
Q2
$212K Hold
1,957
0.19% 42
2018
Q1
$207K Hold
1,957
0.19% 41
2017
Q4
$229K Hold
1,957
0.19% 40
2017
Q3
$222K Hold
1,957
0.2% 40
2017
Q2
$244K Hold
1,957
0.09% 40
2017
Q1
$232K Buy
+1,957
New +$222K 0.06% 41
2016
Q4
Sell
-1,957
Closed -$247K 49
2016
Q3
$247K Buy
+1,957
New +$242K 0.06% 46

Other funds holding ZBH

Armstrong Shaw Associates's ZBH Position: Q3 2023 in Review

Armstrong Shaw Associates held its Zimmer Biomet (ZBH) position steady in Q3 2023 at 1,900 shares worth $213K. The position accounts for 0.22% of the portfolio, ranked #42.

Armstrong Shaw Associates first reported a position in ZBH in Q3 2016 and has held it in 24 quarters since. The position peaked at $306K in Q2 2021. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Armstrong Shaw Associates held 1,900 shares of Zimmer Biomet worth $213K as of Q3 2023.
  • Armstrong Shaw Associates left its Zimmer Biomet share count unchanged in Q3 2023.
  • Zimmer Biomet made up 0.22% of Armstrong Shaw Associates's portfolio in Q3 2023, its #42 holding.
  • Armstrong Shaw Associates first reported a position in Zimmer Biomet in Q3 2016 and has held it in 24 quarters since.
  • Armstrong Shaw Associates's Zimmer Biomet position peaked at $306K in Q2 2021.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Armstrong Shaw Associates's 13F filing for Q3 2023, filed 13 Oct 2023.